Meglitinide (redirect from Glinide)
Meglitinides or glinides are a class of drugs used to treat type 2 diabetes. Repaglinide (trade name Prandin) gained US Food and Drug Administration approval...
4 KB (345 words) - 21:52, 3 April 2023
insulin, glinides, or sulfonylurea, who demonstrate Whipple's triad, it is reasonable to assume the cause of hypoglycemia is due to insulin, glinides, or sulfonylurea...
63 KB (6,112 words) - 14:44, 1 August 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
66 KB (5,434 words) - 17:03, 8 August 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
44 KB (3,480 words) - 15:49, 6 August 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
3 KB (184 words) - 13:53, 14 June 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
4 KB (328 words) - 05:24, 6 August 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
37 KB (3,890 words) - 03:08, 12 August 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
149 KB (14,268 words) - 21:56, 31 July 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
9 KB (284 words) - 09:11, 17 June 2024
Glibornuride Glicaramide Gliclazide# Glimepiride Glipizide Gliquidone Glisoxepide Glyclopyramide Meglitinides/"glinides" Mitiglinide Nateglinide Repaglinide...
16 KB (1,798 words) - 07:40, 1 February 2024